Literature DB >> 29203171

The NLRP3 Inflammasome Renders Cell Death Pro-inflammatory.

Moritz M Gaidt1, Veit Hornung2.   

Abstract

NLRP3 is the most studied inflammasome sensor due to its crucial involvement in sterile and infection-triggered inflammation. Although its molecular mode of activation remains to be defined, it is well established that low intracellular potassium concentrations result in its activation. This functionality allows the classical NLRP3 pathway to serve as a highly sensitive, but non-specific surveillance mechanism responding to any type of perturbation that breaches plasma membrane integrity and the associated potassium gradient across the membrane. Here, we review our current knowledge on potassium efflux-dependent NLRP3 activation, with a special focus on how major cell death programs are rendered pro-inflammatory by secondary NLRP3 activation. Apart from the "alternative inflammasome" as the major exception to the rule, this connection explains the fundamental importance of NLRP3 in cell death-associated inflammation and firmly establishes NLRP3 as a principal surveillance mechanism of cellular integrity.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  IL-1β; Inflammasome; Inflammation; NLRP3; Potassium efflux; programmed cell death

Mesh:

Substances:

Year:  2017        PMID: 29203171     DOI: 10.1016/j.jmb.2017.11.013

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  31 in total

1.  Genetic mitochondrial glycine amidinotransferase protein aggregate formation triggers microparticle sensing and kidney failure.

Authors:  Shrikant R Mulay; Hans-Joachim Anders
Journal:  Ann Transl Med       Date:  2018-08

2.  Wear Particle-induced Priming of the NLRP3 Inflammasome Depends on Adherent Pathogen-associated Molecular Patterns and Their Cognate Toll-like Receptors: An In Vitro Study.

Authors:  Givenchy W Manzano; Brian P Fort; George R Dubyak; Edward M Greenfield
Journal:  Clin Orthop Relat Res       Date:  2018-12       Impact factor: 4.176

Review 3.  Targeting CD39 in cancer.

Authors:  Achim K Moesta; Xian-Yang Li; Mark J Smyth
Journal:  Nat Rev Immunol       Date:  2020-07-29       Impact factor: 53.106

Review 4.  How location and cellular signaling combine to activate the NLRP3 inflammasome.

Authors:  Anil Akbal; Alesja Dernst; Marta Lovotti; Matthew S J Mangan; Róisín M McManus; Eicke Latz
Journal:  Cell Mol Immunol       Date:  2022-09-20       Impact factor: 22.096

Review 5.  Target of MCC950 in Inhibition of NLRP3 Inflammasome Activation: a Literature Review.

Authors:  Danbin Wu; Yefei Chen; Yingxin Sun; Qing Gao; Huhu Li; Zhengfei Yang; Yangxue Wang; Xijuan Jiang; Bin Yu
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

6.  Airborne particulate matter (PM2.5) triggers ocular hypertension and glaucoma through pyroptosis.

Authors:  Liping Li; Chao Xing; Ji Zhou; Liangliang Niu; Bin Luo; Maomao Song; Jingping Niu; Ye Ruan; Xinghuai Sun; Yuan Lei
Journal:  Part Fibre Toxicol       Date:  2021-03-04       Impact factor: 9.400

Review 7.  NLRP3 inflammasome activation and cell death.

Authors:  Yi Huang; Wen Xu; Rongbin Zhou
Journal:  Cell Mol Immunol       Date:  2021-07-28       Impact factor: 22.096

8.  Ox-LDL Causes Endothelial Cell Injury Through ASK1/NLRP3-Mediated Inflammasome Activation via Endoplasmic Reticulum Stress.

Authors:  Liwei Hang; Yan Peng; Rui Xiang; Xiangdong Li; Zhiliang Li
Journal:  Drug Des Devel Ther       Date:  2020-02-24       Impact factor: 4.162

9.  Up-regulation of microRNA-135 or silencing of PCSK6 attenuates inflammatory response in preeclampsia by restricting NLRP3 inflammasome.

Authors:  Xiaolan Zhao; Xun Zhang; Zhao Wu; Jie Mei; Lingling Li; Yujue Wang
Journal:  Mol Med       Date:  2021-07-23       Impact factor: 6.354

Review 10.  The Innate Immune System and Inflammatory Priming: Potential Mechanistic Factors in Mood Disorders and Gulf War Illness.

Authors:  Kyle J Trageser; Maria Sebastian-Valverde; Sean X Naughton; Giulio Maria Pasinetti
Journal:  Front Psychiatry       Date:  2020-07-23       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.